VivoSeq
Other

Nitrous Oxide

0

Pipeline Programs

11

Active Trials

0

Companies Involved

Nitrous Oxide is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

28/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

83/100

Attrition Rate

13/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

67

clinical trials

Completed43 · 64%
Recruiting9 · 13%
Terminated7 · 10%
Unknown status4 · 6%
Not yet recruiting2 · 3%
Withdrawn2 · 3%

Trial Activity

67 trials

Antidepressant Effects of Nitrous Oxide
Recruiting·UUniversity of Chicago·Phase 2·NCT05357040·172 enrolled
Effect of Nitrous Oxide on Aggression.
Recruiting·OOhio State University·Phase 2·NCT06118567·50 enrolled
Nitrous Oxide Neuroimaging
Recruiting··Phase 1·NCT06702631·60 enrolled
Efficacy of Nitrous Oxide in OCD: Pilot Study
Recruiting·SStanford University·Phase 2·NCT03826693·45 enrolled
Page 1 of 5

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)